Molecure Email Format
Biotechnology ResearchMasovian, Poland51-200 Employees
Molecure is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drug candidates that modulate underexplored protein targets and RNA function to address multiple incurable diseases. Its lead program, OATD-01, targets fibrotic and inflammatory conditions, with ongoing trials in interstitial lung diseases such as sarcoidosis and idiopathic pulmonary fibrosis, and a second program, OATD-02, targeting cancer through dual action on tumor immunity and metabolism. The company maintains its headquarters and laboratories in Warsaw and operates additional facilities in Łódź, Poland, positioning itself within the European biotech research landscape. Molecure has built a pipeline across several programs with collaborations and institutional support to advance its drug discovery efforts.